Chan, A. S., Hoang, P., Anbuselvan, A., Chan, S., Zhao, J. J., Ju, Y., Lee, J. J., Tan, T. K., Tam, W. L., Sanda, T., Chow, E., Tripodo, C., Jeyasekharan, A. D. (2025). ATR inhibition with nucleoside analog therapy synergistically overcomes chemoresistance and reprograms dark zone lymphomas toward immune-accessible phenotypes. Blood. https://doi.org/10.1182/blood-2025-1536